• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryCurrent TOCInstructions for authors
J Neurol Neurosurg Psychiatry. Jul 2000; 69(1): 74–81.
PMCID: PMC1737023

CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy

Abstract

OBJECTIVES—To examine the CSF concentrations of molecules reflecting demyelination, neuronal and axonal degeneration, gliosis, monoaminergic neuronal function, and aminergic and peptidergic neurotransmission in a large series of patients with normal pressure hydrocephalus (NPH) or subcortical arteriosclerotic encephalopathy (SAE), to elucidate pathogenic, diagnostic, and prognostic features.
METHODS—CSF concentrations of glycosphingolipid (sulfatide), proteins (neurofilament triplet protein (NFL), glial fibrillary acidic protein (GFAP)), neuropeptides (vasoactive intestinal peptide (VIP), 4-aminobutyric acid (GABA)), and monoamines (homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5-HIAA), 4-hydroxy-3-methoxyphenylglycol (HMPG)) were analysed in 43 patients with NPH and 19 patients with SAE. The diagnoses of NPH and SAE were based on strict criteria and patients with NPH were subsequently operated on. Twelve clinical variables, psychometric tests measuring perceptual speed, accuracy, learning, and memory and a psychiatric evaluation were performed in all patients and before and after a shunt operation in patients with NPH.
RESULTS—The CSF sulfatide concentration was markedly increased in patients with SAE (mean 766, range 300-3800 nmol/l) compared with patients with NPH (mean 206, range 50-400 nmol/l) (p<0.001). 5-HIAA, GABA, and VIP in CSF were higher in patients with SAE than in patients with NPH. The patients with NPH with cerebrovascular aetiology had higher sulfatide concentrations and a poorer outcome after shunt surgery than patients with NPH with other aetiologies.
CONCLUSIONS—The pathogenesis of the white matter changes in NPH and SAE is different and ischaemic white matter changes can be a part of the NPH state. The markedly increased CSF sulfatide concentrations in patients with SAE indicate ongoing demyelination as an important pathophysiological feature of SAE. The CSF sulfatide concentration distinguished between patients with SAE and those with NPH with a sensitivity of 74% and a specificity of 94%, making it an important diagnostic marker.

Full Text

The Full Text of this article is available as a PDF (197K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • ADAMS RD, FISHER CM, HAKIM S, OJEMANN RG, SWEET WH. SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME. N Engl J Med. 1965 Jul 15;273:117–126. [PubMed]
  • Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965 Jul-Aug;2(4):307–327. [PubMed]
  • Milhorat TH, Clark RG, Hammock MK, McGrath PP. Structural, ultrastructural, and permeability changes in the ependyma and surrounding brain favoring equilibration in progressive hydrocephalus. Arch Neurol. 1970 May;22(5):397–407. [PubMed]
  • Milhorat TH. The third circulation revisited. J Neurosurg. 1975 Jun;42(6):628–645. [PubMed]
  • Deo-Narine V, Gomez DG, Vullo T, Manzo RP, Zimmerman RD, Deck MD, Cahill PT. Direct in vivo observation of transventricular absorption in the hydrocephalic dog using magnetic resonance imaging. Invest Radiol. 1994 Mar;29(3):287–293. [PubMed]
  • Weller RO, Wiśniewski H, Shulman K, Terry RD. Experimental hydrocephalus in young dogs: histological and ultrastructural study of the brain tissue damage. J Neuropathol Exp Neurol. 1971 Oct;30(4):613–626. [PubMed]
  • Akai K, Uchigasaki S, Tanaka U, Komatsu A. Normal pressure hydrocephalus. Neuropathological study. Acta Pathol Jpn. 1987 Jan;37(1):97–110. [PubMed]
  • Godersky JC, Graff-Radford NR, Yuh WT. Magnetic resonance imaging of patients with normal pressure hydrocephalus. Adv Neurol. 1990;52:554–554. [PubMed]
  • Bradley WG, Jr, Whittemore AR, Watanabe AS, Davis SJ, Teresi LM, Homyak M. Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus. AJNR Am J Neuroradiol. 1991 Jan-Feb;12(1):31–39. [PubMed]
  • Davis PC, Mirra SS, Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. AJR Am J Roentgenol. 1994 Jun;162(6):1267–1278. [PubMed]
  • Krauss JK, Droste DW, Vach W, Regel JP, Orszagh M, Borremans JJ, Tietz A, Seeger W. Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesions. Neurosurgery. 1996 Aug;39(2):292–300. [PubMed]
  • Babikian V, Ropper AH. Binswanger's disease: a review. Stroke. 1987 Jan-Feb;18(1):2–12. [PubMed]
  • Bennett DA, Wilson RS, Gilley DW, Fox JH. Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):961–965. [PMC free article] [PubMed]
  • Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke. 1995 Jul;26(7):1293–1301. [PubMed]
  • Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Alterations in glia and axons in the brains of Binswanger's disease patients. Stroke. 1997 Jul;28(7):1423–1429. [PubMed]
  • Zhang WW, Olsson Y. The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol. 1997 Mar;93(3):219–224. [PubMed]
  • Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia. 1994 May-Aug;5(3-4):145–147. [PubMed]
  • Bracco L, Campani D, Baratti E, Lippi A, Inzitari D, Pracucci G, Amaducci L. Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study. J Neurol Sci. 1993 Dec 15;120(2):131–136. [PubMed]
  • Graff-Radford NR, Godersky JC. Idiopathic normal pressure hydrocephalus and systemic hypertension. Neurology. 1987 May;37(5):868–871. [PubMed]
  • Koto A, Rosenberg G, Zingesser LH, Horoupian D, Katzman R. Syndrome of normal pressure hydrocephalus: possible relation to hypertensive and arteriosclerotic vasculopathy. J Neurol Neurosurg Psychiatry. 1977 Jan;40(1):73–79. [PMC free article] [PubMed]
  • Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelsö C. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology. 1998 Apr;50(4):1122–1127. [PubMed]
  • Sutton LN, Wood JH, Brooks BR, Barrer SJ, Kline M, Cohen SR. Cerebrospinal fluid myelin basic protein in hydrocephalus. J Neurosurg. 1983 Sep;59(3):467–470. [PubMed]
  • Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, Gottfries CG, Blennow K. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology. 1998 Apr;50(4):966–971. [PubMed]
  • Wikkelsø C, Blomstrand C. Cerebrospinal fluid proteins and cells in normal-pressure hydrocephalus. J Neurol. 1982;228(3):171–180. [PubMed]
  • Larsson A, Moonen M, Bergh AC, Lindberg S, Wikkelsö C. Predictive value of quantitative cisternography in normal pressure hydrocephalus. Acta Neurol Scand. 1990 Apr;81(4):327–332. [PubMed]
  • Wikkelsö C, Andersson H, Blomstrand C, Lindqvist G, Svendsen P. Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test. Acta Neurol Scand. 1986 Jun;73(6):566–573. [PubMed]
  • Larsson A, Bergh AC, Bilting M, Arlig A, Jacobsson L, Stephensen H, Wikkelsö C. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur J Nucl Med. 1994 Feb;21(2):118–123. [PubMed]
  • Graff-Radford NR, Rezai K, Godersky JC, Eslinger P, Damasio H, Kirchner PT. Regional cerebral blood flow in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 1987 Dec;50(12):1589–1596. [PMC free article] [PubMed]
  • Larsson A, Wikkelsö C, Bilting M, Stephensen H. Clinical parameters in 74 consecutive patients shunt operated for normal pressure hydrocephalus. Acta Neurol Scand. 1991 Dec;84(6):475–482. [PubMed]
  • Blomsterwall E, Bilting M, Stephensen H, Wikkelsö C. Gait abnormality is not the only motor disturbance in normal pressure hydrocephalus. Scand J Rehabil Med. 1995 Dec;27(4):205–209. [PubMed]
  • Lindqvist G, Andersson H, Bilting M, Blomstrand C, Malmgren H, Wikkelsø C. Normal pressure hydrocephalus: psychiatric findings before and after shunt operation classified in a new diagnostic system for organic psychiatry. Acta Psychiatr Scand Suppl. 1993;373:18–32. [PubMed]
  • Blennow K, Wallin A, Gottfries CG, Månsson JE, Svennerholm L. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J Neural Transm Park Dis Dement Sect. 1993;5(1):5–15. [PubMed]
  • Davidsson P, Fredman P, Månsson JE, Svennerholm L. Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. Clin Chim Acta. 1991 Mar 15;197(2):105–115. [PubMed]
  • Fredman P, Wallin A, Blennow K, Davidsson P, Gottfries CG, Svennerholm L. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurol Scand. 1992 Feb;85(2):103–106. [PubMed]
  • Widerlöv E, Lindström LH, Wahlestedt C, Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res. 1988;22(1):69–79. [PubMed]
  • Wikkelsö C, Ekman R, Westergren I, Johansson B. Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia. Eur Neurol. 1991;31(2):88–93. [PubMed]
  • Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol. 1995 Dec;26(3):231–245. [PubMed]
  • Lekman A, Fredman P. A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid. Neurochem Int. 1998 Aug;33(2):103–108. [PubMed]
  • Goldsmith RF, Earl JW, Cunningham AM. Determination of delta-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography. Clin Chem. 1987 Oct;33(10):1736–1740. [PubMed]
  • Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelsø C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996 Nov;67(5):2013–2018. [PubMed]
  • Rosengren LE, Wikkelsø C, Hagberg L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods. 1994 Mar;51(2):197–204. [PubMed]
  • Rosengren B, Fredman P, Månsson JE, Svennerholm L. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain. J Neurochem. 1989 Apr;52(4):1035–1041. [PubMed]
  • Svennerholm L, Boström K, Fredman P, Jungbjer B, Månsson JE, Rynmark BM. Membrane lipids of human peripheral nerve and spinal cord. Biochim Biophys Acta. 1992 Sep 22;1128(1):1–7. [PubMed]
  • Malm G, Ringdén O, Winiarski J, Gröndahl E, Uyebrant P, Eriksson U, Håkansson H, Skjeldal O, Månsson JE. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant. 1996 Jun;17(6):1003–1008. [PubMed]
  • Pantoni L, Garcia JH, Brown GG. Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci. 1996 Feb;135(2):131–139. [PubMed]
  • Bech RA, Juhler M, Waldemar G, Klinken L, Gjerris F. Frontal brain and leptomeningeal biopsy specimens correlated with cerebrospinal fluid outflow resistance and B-wave activity in patients suspected of normal-pressure hydrocephalus. Neurosurgery. 1997 Mar;40(3):497–502. [PubMed]
  • Albrechtsen M, Sørensen PS, Gjerris F, Bock E. High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus. J Neurol Sci. 1985 Oct;70(3):269–274. [PubMed]
  • Rosengren LE, Karlsson JE, Sjögren M, Blennow K, Wallin A. Neurofilament protein levels in CSF are increased in dementia. Neurology. 1999 Mar 23;52(5):1090–1093. [PubMed]
  • Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett. 1997 Apr 11;225(3):210–212. [PubMed]
  • Malm J, Kristensen B, Ekstedt J, Adolfsson R, Wester P. CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters. J Neurol Neurosurg Psychiatry. 1991 Mar;54(3):252–259. [PMC free article] [PubMed]
  • Wikkelsø C, Fahrenkrug J, Blomstrand C, Johansson BB. Dementia of different etiologies: vasoactive intestinal polypeptide in CSF. Neurology. 1985 Apr;35(4):592–595. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...